OncoSec Medical Incorporated (ONCS)
US68234L4059 - Common Stock
Why Is Virgin Galactic (SPCE) Stock Down 13% Today?
Virgin Galactic (SPCE) stock is falling on Friday after the company announced a $400 million stock sale agreement today.
Why Is Spark Networks (LOV) Stock Down 42% Today?
Spark Networks (LOV) stock is taking a beating on Friday with a forbearance period update and an upcoming delisting this month.
Why Is Castellum (CTM) Stock Up 64% Today?
Castellum (CTM) stock is surging higher on Friday with heavy trading despite a lack of news from the information technology company.
Why Is OncoSec Medical (ONCS) Stock Up 100% Today?
OncoSec Medical (ONCS) stock is taking off on Friday after the company received a delisting notice that it doesn't intend to appeal.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time for a final dive into the biggest pre-market stock movers this week as we check out what's happening on Friday!
XPEV Stock Alert: Xpeng Expands Assisted Driving Tech
Xpeng (XPEV) stock is on the move Thursday after the Chinese EV company expanded its assisted driving technology to Beijing.
Why Are Chinese Stocks BABA, JD, PDD Up Today?
Chinese stocks are on the rise Thursday as investors react to Alibaba (BABA) expansion plans and lowered interest rates.
Why Is OncoSec Medical (ONCS) Stock Down 48% Today?
OncoSec Medical (ONCS) stock is falling hard on Thursday after the clinical-stage biotechnology company filed for bankruptcy.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start breaking down the biggest pre-market stock movers for Thursday as we get ready for another busy day of trading!
OncoSec Announces Closing of $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
/PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company developing intratumoral...
OncoSec Announces $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
/PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company developing intratumoral...
OncoSec Receives $3.49 Million to Strengthen its Balance Sheet After Selling its Net Operating Loss Tax Benefits Through The New Jersey Economic Development Authority NOL Program
/PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the Company or OncoSec), a clinical-stage biotechnology company developing intratumoral...
OncoSec Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
/PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company developing intratumoral...
OncoSec Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
/PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company developing intratumoral...
PXD, TGTX and EH among pre-market gainers
OncoSec Medical (ONCS) +65%. GlucoTrack (GCTK) +29%
OncoSec stock falls after TAVO-EP/Keytruda combo fails skin cancer trial
OncoSec Medical's (ONCS) TAVO-EP, Merck's (MRK) Keytruda combo did not meet the main goal in skin cancer trial. Read more here
OncoSec Announces Clinical Data of the KEYNOTE-695 Trial Assessing TAVO™-EP in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Melanoma Refractory to anti-PD-1 Treatment
/PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the Company or OncoSec), a clinical-stage biotechnology company developing intratumoral...